Possible Setback For Califf On Road To FDA

Rob Califf may have just run into his first serious roadblock on his path to become the FDA’s next commissioner. According to a report in the Boston Globe, Califf removed his name as a co-author from a series of papers, some of which were critical of current FDA policy. Until now Califf’s nomination has not encountered a...Click here to continue reading...

Source: CardioBrief - October 7, 2015 Category: Cardiology Authors: Larry Husten Tags: People, Places & Events Policy & Ethics Califf clinical trials FDA Source Type: blogs